Today I want to focus on a change that many hospitals may have overlooked.
The Centers for Medicare & Medicaid Services (CMS) recently inserted a new schedule into the Medicare cost report called Worksheet S-12. At first glance, it looks like just another reporting requirement.
But it’s much bigger than that.
In fact, I believe Worksheet S-12 is the first visible sign of what could become the biggest change to Medicare inpatient reimbursement that most of us will see in our careers.
For decades, Medicare has determined Diagnosis-Related Group (DRG) payments using its own cost-based methodology.
Now CMS is asking hospitals to report something very different. Beginning with their 2026 cost report, hospitals must disclose the weighted median Medicare Advantage (MA) reimbursement they receive from every MA payer, for every MS-DRG.
The obvious question is…why?
Because CMS plans to use that information to help determine Medicare fee-for-service payments beginning in the 2029 fiscal year (FY).
Think about what that means.
For the first time, Medicare is looking to the market to help determine what Medicare itself should pay.
That’s a fundamental shift. Instead of the government telling the market what healthcare is worth, the market will begin influencing what the government pays.
That’s why I think Worksheet S-12 is so important. It’s not really about the worksheet, but where Medicare reimbursement is headed.
So, how should hospitals prepare?
I think about it in three phases.
First is the short term.
Right now, it’s about compliance.
Hospitals must accurately calculate and report their MA reimbursement by MS-DRG. But here’s where price transparency comes into play: the data for Worksheet S-12 must come directly from the hospital’s machine-readable file.
That means price transparency has taken on an entirely new level of importance.
For years, hospitals viewed machine-readable files primarily as a compliance requirement, with the biggest risk being CMS enforcement or civil monetary penalties.
That’s no longer the case.
If your machine-readable file doesn’t accurately reflect your negotiated MA reimbursement, it could negatively influence the data CMS uses to shape your future Medicare payment rates.
The financial stakes are now dramatically higher.
What was once a transparency exercise has become a strategic financial asset that deserves the same level of governance as your chargemaster, managed care contracts, and Medicare cost report.
The second phase is understanding the data.
Historically, hospitals knew their own negotiated rates, but they had very little idea where those rates stood relative to the rest of the market.
Machine-readable files change that.
For the first time, hospitals can benchmark their MA reimbursement against competitors – and understand their true market position.
Which DRGs are above-market?
Which are below?
Where do you have leverage in your next negotiation?
That’s a completely different conversation than hospitals have had in the past.
It’s no longer just about contract management. It’s about market intelligence.
And if Medicare reimbursement increasingly reflects negotiated market rates, improving your MA contracts today could strengthen both your MA revenue and your future Medicare reimbursement.
That is a strategic leadership opportunity.
Then comes the long term.
If this is the direction CMS is headed, hospitals will need much stronger capabilities in managed care analytics, strategic pricing, contract modeling, revenue integrity, and financial forecasting.
This isn’t just a reimbursement department issue.
Ultimately, it’s a board-level strategic issue, because it has the potential to influence one of most hospitals’ largest revenue streams.
At Panacea, we’ve spent years helping hospitals with reimbursement, strategic pricing, managed care analytics, revenue integrity, and price transparency. We intend to play a leading role in working with hospitals, because the implications of Worksheet S-12 bring all of those disciplines together.
The hospitals that succeed won’t simply be the ones that file an accurate cost report.
They’ll be the ones that recognize where Medicare reimbursement is headed, use data to negotiate from a position of strength, and turn this regulatory change into a long-term competitive advantage.
I’ll leave you with one final thought.
Worksheet S-12 may look like just another Medicare cost report requirement.
I think it’s actually the clearest signal yet that Medicare reimbursement is beginning to move from a government-designed payment methodology toward one increasingly shaped by negotiated market rates.
But this change gives hospitals something they’ve never really had before: greater influence over their future Medicare reimbursement through smarter pricing, stronger managed care negotiations, better data, and more informed financial strategy.
That’s a remarkable shift.
So don’t think of Worksheet S-12 as another cost report schedule.
Think of it as the beginning of a new era: one where hospitals have more opportunity than ever to shape, rather than simply react to, their Medicare reimbursement.
